Division News

The National Institutes of Health has awarded a research program project grant to Mary Klotman, MD, professor of medicine (Infectious Diseases). The award will last five years, and will total more than $9 million.

The program project, "Integrase Defective Lentiviral Vector (IDLV)-ENV Immunogen Strategy for an HIV Vaccine," is supported by the National Institute Of Allergy and Infectious Diseases under award number P01AI110485.

Three of the nation’s largest philanthropies – the Howard Hughes Medical Institute, the Bill & Melinda Gates Foundation, and the Simons Foundation – have announced a new partnership to provide much needed research support to outstanding early-career scientists in the United States.

Through the new Faculty Scholars Program, the philanthropies will invest a total of $148 million in research support over the program’s first five years.

Mary Klotman, MD, chair of the department, and Scott Palmer, MD, MHS, vice chair for research, announced the recipients of the 2015 Chair’s Research Award, and the newly created K-bridge funding program. Both awards fund junior investigators who are making the transition to becoming independent scientists prior to their acquisition of extramural funding.

Nearly 200 One Health researchers from around the world gathered at the inaugural International Symposium on One Health Research (ISOHR) at Guangzhou, China this past weekend. Division of Infectious Diseases faculty members Gregory Gray and Christopher Woods participated. Read the full article.

Given the rapidly changing national and international response to Ebola, Duke University and Duke Medicine have established a centralized information resource to provide ongoing updates to employees, students, patients and other members of the Duke community. The

Read more at Duke Today.

Thomas Holland, MD, medical instructor in the Division of Infectious Diseases and hospitalist at Duke University Hospital, coauthored a JAMA review of evidence of management strategies for S aureus bacteremia to determine whether transesophageal echocardiography is necessary in all adult cases and what is the optimal antibiotic therapy for methicillin-resistant S aureus (MRSA) bacteremia. Read the review article.

Thomas Holland, MD, medical instructor in the Division of Infectious Diseases and hospitalist at Duke University Hospital, coauthored a JAMA review of evidence of management strategies for S aureus bacteremia to determine whether transesophageal echocardiography is necessary in all adult cases and what is the optimal antibiotic therapy for methicillin-resistant S aureus (MRSA) bacteremia. Read the review article.

The Antibiotic Resistance Leadership Group (ARLG), based at Duke as part of a six-year, $62 million federal grant to Vance Fowler, MD, MHS, and a group of researchers at Duke and across the country (learn more), is mentioned as an important part of a new ex

The Antibiotic Resistance Leadership Group (ARLG), based at Duke as part of a six-year, $62 million federal grant to Vance Fowler, MD, MHS, and a group of researchers at Duke and across the country (learn more), is mentioned as an important part of a new ex